Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

KLINIKEJENDOMMEN HOBRO ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   0.4% 0.4% 0.4% 0.4% 0.4% 0.4% 0.4% 0.4%   Bankruptcy risk   4.5% 3.1% 2.2% 3.1% 3.0% 2.4% 10.2% 10.0%   Credit score (0-100)   48 57 66 55 57 63 24 24   Credit rating   BBB BBB BBB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   319 332 331 380 381 376 0.0 0.0   EBITDA   319 332 331 380 381 376 0.0 0.0   EBIT   294 342 301 660 251 426 0.0 0.0   Pre-tax profit (PTP)   261.1 316.1 286.0 648.1 241.5 416.4 0.0 0.0   Net earnings   203.6 246.1 222.3 505.2 188.3 324.6 0.0 0.0   Pre-tax profit without non-rec. items   261 316 286 648 242 416 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   4,120 4,130 4,100 4,380 4,250 4,300 0.0 0.0   Shareholders equity total   1,418 1,556 1,668 2,060 2,134 2,341 2,094 2,094   Interest-bearing liabilities   2,135 1,935 1,909 1,684 1,525 1,389 0.0 0.0   Balance sheet total (assets)   4,120 4,130 4,130 4,380 4,265 4,342 2,094 2,094   Net Debt   2,135 1,935 1,909 1,684 1,510 1,348 -2,094 -2,094     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   319 332 331 380 381 376 0.0 0.0   Gross profit growth   46.9% 4.0% -0.5% 14.9% 0.1% -1.2% -100.0% 0.0%   Employees   1 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   4,120 4,130 4,130 4,380 4,265 4,342 2,094 2,094   Balance sheet change%   -0.6% 0.2% 0.0% 6.0% -2.6% 1.8% -51.8% 0.0%   Added value   294.3 342.3 300.8 660.2 250.6 426.1 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -25 10 -30 280 -130 50 -4,300 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   92.1% 103.0% 90.9% 173.6% 65.8% 113.3% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   7.1% 8.3% 7.3% 15.5% 5.8% 9.9% 0.0% 0.0%   ROI %   7.3% 8.5% 7.4% 15.7% 5.9% 10.0% 0.0% 0.0%   ROE %   14.9% 16.5% 13.8% 27.1% 9.0% 14.5% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   34.4% 37.7% 40.4% 47.0% 50.0% 53.9% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   668.4% 582.2% 577.2% 442.9% 396.8% 358.3% 0.0% 0.0%   Gearing %   150.6% 124.3% 114.5% 81.7% 71.5% 59.4% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   1.5% 1.3% 0.8% 0.7% 0.6% 0.7% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0   Current Ratio   0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0   Cash and cash equivalent   0.0 0.0 0.0 0.0 14.6 41.9 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -253.4 -261.4 -260.4 -223.7 -183.4 -150.1 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   294 342 301 660 251 426 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   319 332 331 380 381 376 0 0   EBIT / employee   294 342 301 660 251 426 0 0   Net earnings / employee   204 246 222 505 188 325 0 0